Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Stabilis Solutions
SLNG
$88.9M
| $130K | ﹤0.01% |
+24,500
| New | +$177K |
|
|
YARW
3552
Yarrow Bioscience, Inc. Common Stock
YARW
$25.3M
| $130K | ﹤0.01% |
963
-69
| -7% | -$13.8K |
|
3553
Loop Industries
LOOP
$35.2M
| $129K | ﹤0.01% |
+54,111
| New | +$157K |
|
3554
Mega Matrix
MPU
$15.8M
| $129K | ﹤0.01% |
73,500
-66,526
| -48% | -$126K |
|
|
AUMN
3555
DELISTED
Golden Minerals Company
AUMN
| $129K | ﹤0.01% |
18,829
+5,157
| +38% | +$33.8K |
|
3556
Fusion Fuel Green
HTOO
$18M
| $128K | ﹤0.01% |
826
+220
| +36% | +$34.5K |
|
3557
Lantern Pharma
LTRN
$35.1M
| $127K | ﹤0.01% |
21,100
-200
| -0.9% | -$1K |
|
3558
Sportradar
SRAD
$3.82B
| $127K | ﹤0.01% |
12,800
-24,300
| -65% | -$237K |
|
3559
Monte Rosa Therapeutics
GLUE
$1.36B
| $125K | ﹤0.01% |
+16,400
| New | +$137K |
|
3560
Bank Of The James
BOTJ
$123M
| $124K | ﹤0.01% |
+10,376
| New | +$123K |
|
3561
MoonLake Immunotherapeutics
MLTX
$1.53B
| $122K | ﹤0.01% |
+11,609
| New | +$103K |
|
3562
Cyclerion Therapeutics
CYCN
$15.2M
| $120K | ﹤0.01% |
9,179
-4,990
| -35% | -$59K |
|
|
CDAK
3563
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $120K | ﹤0.01% |
300,852
+232,552
| +340% | +$153K |
|
3564
US Global Investors
GROW
$37M
| $119K | ﹤0.01% |
41,323
+2,008
| +5% | +$5.75K |
|
3565
Holley
HLLY
$341M
| $119K | ﹤0.01% |
56,200
-33,600
| -37% | -$106K |
|
|
AAU
3566
DELISTED
Almaden Minerals Ltd
AAU
| $119K | ﹤0.01% |
+488,823
| New | +$117K |
|
|
WHLM
3567
DELISTED
Wilhelmina International, Inc
WHLM
| $118K | ﹤0.01% |
33,400
-6,612
| -17% | -$25.6K |
|
3568
FinWise Bancorp
FINW
$193M
| $117K | ﹤0.01% |
12,600
+600
| +5% | +$5.5K |
|
3569
Fastly Inc
FSLY
$3.9B
| $117K | ﹤0.01% |
14,300
-1,200
| -8% | -$10.5K |
|
|
LYRA
3570
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $117K | ﹤0.01% |
744
-56
| -7% | -$11.1K |
|
|
SGRP
3571
DELISTED
SPAR Group
SGRP
| $116K | ﹤0.01% |
89,500
+27,500
| +44% | +$40.5K |
|
|
SLAI
3572
DELISTED
SOLAI Ltd ADS
SLAI
| $115K | ﹤0.01% |
10,416
+7,167
| +221% | +$111K |
|
3573
Sidus Space
SIDU
$217M
| $115K | ﹤0.01% |
1,059
+98
| +10% | +$16.6K |
|
|
BBLN
3574
DELISTED
Babylon Holdings Limited
BBLN
| $115K | ﹤0.01% |
17,092
+780
| +5% | +$9.1K |
|
|
GRCL
3575
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $113K | ﹤0.01% |
49,000
-1,300
| -3% | -$3.98K |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.